Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Aquestive Therapeutics, Inc.
13G
AQST · 03843E104
|
7.5% |
10/7/2026
Event 10/7/2026
|
|||
| Bass Edward P | 7.5% | ||||
| Thru Line L.P. | 6.3% | ||||